Back to search
FDAFDA · Food and drugs·Recall number D-0650-2017

Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09

Published April 12, 2017 · Recall initiated: December 7, 2015

Summary

FDA records drug Class III recall D-0650-2017, published April 12, 2017 and initiated December 7, 2015. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 15,168 bottes; Lot: Batch number G303703, exp 3/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; Impurity A

What to do

Voluntary: Firm initiated · E-Mail

Get an email if QUINAPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
QUINAPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide
UPC
0368180559092
Lot
Batch number G303703, exp 3/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09 recalled?

Yes. FDA published recall D-0650-2017 on April 12, 2017. Reported hazard: Failed Impurities/Degradation Specifications; Impurity A

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: QUINAPRIL. UPC: 0368180559092.